The inhibitory receptor Siglec-E controls antigen-presenting cell activation and T cell–mediated transplant rejection

Journal:

Science Translational Medicine

Published:

2025-05-07

DOI:

10.1126/scitranslmed.ads2694

Affiliations:

9

Authors:

18

Go to article

Institutions	Authors	Share
Massachusetts General Hospital (MGH), United States of America (USA)	13.000000 13.000000	0.72
University of California, San Diego (UC San Diego), United States of America (USA)	2.000000	0.11
Federal University of Health Sciences of Porto Alegre (UFCSPA), Brazil	1.000000	0.06
Beth Israel Deaconess Medical Center (BIDMC), United States of America (USA)	1.000000	0.06
Lerner Research Institute, Cleveland Clinic, United States of America (USA)	0.500000	0.03
Cleveland Clinic, United States of America (USA)	0.500000	0.03

Interested in Immunology?